CAAS Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-96,710
| Closed | -$977K | – | 650 |
|
|
2022
Q4 | $977K | Hold |
96,710
| – | – | 0.06% | 75 |
|
|
2022
Q3 | $958K | Hold |
96,710
| – | – | 0.05% | 141 |
|
|
2022
Q2 | $947K | Buy |
+96,710
| New | +$947K | 0.05% | 140 |
|
|
2022
Q1 | – | Sell |
-96,710
| Closed | -$937K | – | 706 |
|
|
2021
Q4 | $937K | Hold |
96,710
| – | – | 0.02% | 166 |
|
|
2021
Q3 | $935K | Buy |
+96,710
| New | +$935K | 0.02% | 251 |
|